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Abstract
Although metabotropic glutamate receptor 5 (mGluR5) is essential for cocaine self-administration and drug-
seeking behavior, there is limited knowledge of the cellular actions of this receptor in the nucleus accumbens
(NAc). Although mGluR5 has the potential to regulate neurons directly, recent studies have shown the
importance of mGluR5 in regulating Ca(2+) signaling in astrocytes and, as a consequence, the Ca(2+)-
dependent release of excitatory transmitters from these glia. In this study, we demonstrate that activation of
mGluR5 induces Ca(2+) oscillations in NAc astrocytes with the correlated appearance of NMDA receptor-
dependent slow inward currents detected in medium spiny neurons (MSNs). Photolysis of caged Ca(2+)
loaded specifically into astrocytes evoked slow inward currents demonstrating that Ca(2+) elevations in
astrocytes are responsible for these excitatory events. Pharmacological evaluation of these glial-evoked
NMDA currents shows that they are mediated by NR2B-containing NMDA receptors, whereas synaptic
NMDA receptors rely on NR2A-containing receptors. Stimulation of glutamatergic afferents activates
mGluR5-dependent astrocytic Ca(2+) oscillations and gliotransmission that is sustained for minutes beyond
the initial stimulus. Because gliotransmission is mediated by NMDA receptors, depolarized membrane
potentials exhibited during up-states augment excitation provided by gliotransmission, which drives bursts of
MSN action potentials. Because the predominant mGluR5-dependent action of glutamatergic afferents is to
cause the sustained activation of astrocytes, which in turn excite MSNs through extrasynaptic NMDA
receptors, our results raise the potential for gliotransmission being involved in prolonged mGluR5-dependent
adaptation in the NAc.
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Although metabotropic glutamate receptor 5 (mGluR5) is essential for
cocaine self-administration and drug-seeking behavior, there is lim-
ited knowledge of the cellular actions of this receptor in the nucleus
accumbens (NAc). Although mGluR5 has the potential to regulate
neurons directly, recent studies have shown the importance of
mGluR5 in regulating Ca2 signaling in astrocytes and, as a conse-
quence, the Ca2-dependent release of excitatory transmitters from
these glia. In this study, we demonstrate that activation of mGluR5
induces Ca2 oscillations in NAc astrocytes with the correlated ap-
pearance of NMDA receptor-dependent slow inward currents de-
tected in medium spiny neurons (MSNs). Photolysis of caged Ca2
loaded specifically into astrocytes evoked slow inward currents dem-
onstrating that Ca2 elevations in astrocytes are responsible for these
excitatory events. Pharmacological evaluation of these glial-evoked
NMDA currents shows that they are mediated by NR2B-containing
NMDA receptors, whereas synaptic NMDA receptors rely on NR2A-
containing receptors. Stimulation of glutamatergic afferents activates
mGluR5-dependent astrocytic Ca2 oscillations and gliotransmission
that is sustained for minutes beyond the initial stimulus. Because
gliotransmission is mediated by NMDA receptors, depolarized mem-
brane potentials exhibited during up-states augment excitation pro-
vided by gliotransmission, which drives bursts of MSN action poten-
tials. Because the predominant mGluR5-dependent action of
glutamatergic afferents is to cause the sustained activation of astro-
cytes, which in turn excite MSNs through extrasynaptic NMDA re-
ceptors, our results raise the potential for gliotransmission being
involved in prolonged mGluR5-dependent adaptation in the NAc.
addiction  astrocytes  glutamate release  NMDA receptors
Although the dopaminergic system is known to play importantroles in responses to drugs of abuse, there is an increasing
awareness of the importance of glutamate in mediating effects of
these drugs in the brain (1). Cocaine administration requires
glutamatergic transmission in the nucleus accumbens (NAc) for
drug-seeking behavior (2, 3) with accumulating evidence demon-
strating the importance of metabotropic glutamate receptors
(mGluRs) in mediating the actions of extracellular glutamate after
cocaine use (4). mGluR5 knockout mice do not acquire cocaine
self-administration behavior (4), and in wild-type mice the mGluR5
antagonist, 2-methyl-6-(phenylethynyl)pyridine hydrochloride
(MPEP), decreases cocaine, morphine, and nicotine self-
administration and drug-seeking behavior (5–8).
Although astrocytes are electrically inexcitable, emerging evi-
dence demonstrates that these nonneuronal cells respond to neu-
rotransmitters with elevations in their internal Ca2 and with the
release of the chemical transmitters glutamate, ATP and D-serine
(9, 10). Because astrocytes and neurons release common chemical
transmitters, we use the term gliotransmitter and gliotransmission
to refer to their release from astrocytes (11). Recent molecular
genetic manipulation of astrocytes has shown that through the
release of gliotransmitters, astrocytes can coordinate synaptic net-
works in the hippocampus (12). Moreover, several lines of evidence
show that astrocytes express class I mGluRs, in particular mGluR5
(13–15), which when activated can induce gliotransmission (15).
Class I mGluRs are critical for gliotransmission in the hippocam-
pus and cortex; however, there is little information concerning this
receptor system in glial cells elsewhere in the nervous system. Drugs
of abuse have convergent actions in the NAc suggesting that this is
an important brain region mediating rewarding properties (16, 17).
Because of the powerful excitation provided by astrocytes to
pyramidal neurons in the hippocampus (18, 19), and because
mGluR5 is critical for drug-seeking behavior (4), we have asked
whether mGluR5-dependent gliotransmission regulates medium
spiny neuron (MSN) excitability in the NAc and thus whether
gliotransmission has the potential to provide an excitatory signal
underlying the reward pathway that is centered in the NAc.
Results
mGluR5-Dependent Ca2 Signaling in Astrocytes. We used brain slices
from pGFAP-GFP mice, in which the glial fibrillary acidic protein
promoter drives the expression of GFP (20) for fluorescence-
guided patch-clamping. GFP fluorescent cells have small (10 m)
somata with highly ramified processes (Fig. 1A). Action potentials
were never evoked when currents were injected in current-clamp
mode into GFP-expressing cells (Fig. 1B; n  15), and they
displayed a more negative resting potential than MSNs [89.7  1.4
mV, n  15; see supporting information (SI) Table 1]. GFP-
expressing cells have a linear current/voltage relationship (Fig. 1C),
typical of passive astrocytes in other brain regions (21, 22) with an
input resistance of 17.8  3.0 M (n  15). To assess whether the
GFP-positive cells in the NAc are gap junction-coupled, we per-
formed paired recording from two GFP-positive cells. Depolariza-
tion caused bidirectional current flow between paired cells (n  3
pairs; Fig. 1D). When Alexa 568 was included in pipette solution,
dye coupling was detected in adjacent GFP-labeled cells (SI Fig. 6).
Although it is known that MSNs express mGluR5, it is unknown
whether astrocytes express this group I metabotropic receptor. The
expression of mGluR5 in the NAc was confirmed by using Western
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blot analysis and immunocytochemistry (Fig. 1 E–G). mGluR5
immunoreactivity was widespread throughout the NAc, consistent
with both neuronal and glial labeling (data not shown). To ask
whether astrocytes express this receptor, we performed immuno-
cytochemistry in GFAP-GFP transgenic mice and used the pres-
ence of GFP expression in astrocytes to make an image mask (see
SI Materials and Methods) to ask whether mGluR5 immunoreac-
tivity was associated with astrocytic processes. mGluR5 immuno-
reactivity colocalized with GFP-expressing astrocytic processes and
to a lesser extent with the astrocytic cell body and the endfeet that
contact the vasculature (Fig. 1 E–G).
To investigate Ca2 excitability, slices from pGFAP-GFP mice
(20) were incubated with the red-shifted Ca2 indicator Rhod-2
AM. Bulk loaded Ca2 indicator selectively accumulated in GFP-
expressing astrocytes (Fig. 1H), which display the typical passive
properties of NAc astrocytes (Fig. 1 I and J). Although spontaneous
Ca2 oscillations within NAc astrocytes are detected infrequently
(Fig. 1L), application of the class I mGluR agonist (RS)-3,5-
dihydroxyphenylglycine (DHPG) (20 M) resulted in Ca2 tran-
sients that were attenuated by the mGluR5 antagonist MPEP (Fig.
1 K and L). ATP (50 M) and baclofen (40 M), a GABAB agonist,
resulted in intracellular Ca2 elevations in astrocytes (Fig. 1 K and
L). In agreement with the properties of cortical and hippocampal
astrocytes (23), perfusion of NAc slices with a low extracellular
Ca2 artificial cerebrospinal fluid (ACSF) induced astrocytic Ca2
oscillations (Fig. 1L). In contrast, astrocytic Ca2 signals (Fig. 1L)
were not evoked by cocaine (1–10 M), the dopamine D1 receptor
agonist SKF 38393 (2.5–5 M), or the dopamine D2 agonist
quinpirole (20 M).
mGluR5 Induces Ca2-Dependent Gliotransmission. To ask whether
mGluR5-dependent Ca2 signaling induces gliotransmission and
excites MSNs, we recorded from MSNs in the virtual absence of
extracellular Mg2, to relieve the Mg2 block of the NMDA
receptors, and in tetrodotoxin (TTX) (1 M), to block action
potential-mediated release from glutamatergic inputs. Slow tran-
sient inward currents were detected with kinetics significantly
slower than excitatory postsynaptic currents (EPSCs) (Fig. 2B) but
similar to the astrocyte-dependent slow inward currents (SICs)
previously recorded in the hippocampus (Fig. 2 A and B and SI
Table 2) (15, 18, 19). Paired whole-cell recordings from closely
spaced (80 m) MSNs revealed that SICs can occur in two
neurons with a high degree of temporal correlation (Fig. 2C). In 11
paired recordings, 7 displayed SICs: of 55 SICs, 16 (29.1%) were
found to be synchronized within a time window of 200 ms (Fig. 2D).
DHPG (20 M) caused a slow depolarization in a subpopulation
(56%) of MSNs and significantly increased the frequency of SICs
(n  15; Fig. 2 E and F). ATP, baclofen, or low Ca2 ACSF, stimuli
that we showed to effectively trigger Ca2 increases in NAc
astrocytes (Fig. 1L), caused a significant increase in the frequency
of SICs in MSNs (Fig. 2F). Cocaine, or the D1 and D2 receptor
agonists SKF 38393 and quinpirole, which did not activate astrocytic
Ca2 signaling, did not stimulate SICs (Fig. 2F).
To determine whether the slow currents are generated by a
Ca2-dependent gliotransmission, we selectively stimulated single
astrocytes using photolysis of the Ca2 cage NP-EGTA. We focused
a UV beam (3-m diameter) to an astrocytic cell body at a distance
from dendrites of the recorded MSN. Photolysis evoked a Ca2
elevation in the astrocyte cell body and caused delayed SICs in
adjacent neurons (SI Fig. 7 A and B; n  5 of 16). This delay results
from the time required for propagation of the Ca2 signal from the
cell body to the distal processes. When NP-EGTA was omitted, UV
photolysis evoked neither an astrocytic Ca2 elevation nor an SIC
in the associated pyramidal neuron (n  5).
NR2B Subunit-Containing NMDA Receptors Are Activated by Glio-
transmission. SICs were reversibly attenuated by the specific
NMDA receptor antagonist D-AP5 (50–100 M; SI Fig. 7D) and
Fig. 1. NAc astrocytes are electrically inexcitable, are electrotonically cou-
pled with one another, express mGluR5 receptors, and respond to neurotrans-
mitters with Ca2 oscillations. (A) Two-photon laser-scanning image of GFP-
expressing cells from a NAc slice obtained from pGFAP-GFP transgenic mice
(z-projection of 15 planes). (Scale bar: Upper, 40 m; Lower, 10 m.) An
astrocytic endfoot making contact with a capillary (*). (B) Typical response of
a NAc pGFAP-GFP cell to current injections from 0.2 to 1.1 nA (bottom
traces, 0.1-nA increments). (C) Average whole-cell I–V relationship from GFP-
expressing cells (n  15 cells). (Inset) Inward and outward currents recorded in
voltage-clamp configurations (135 to 25 mV, 10-mV increments). (Scale
bars: 2 nA, 50 ms.) (D) Paired recordings from two GFP-positive cells showing
bidirectional coupling. (E–G) mGluR5 is expressed in NAc astrocytes. Top-view
reconstruction obtained from confocal z-series of GFP-expressing astrocytes
(E, green). mGluR5 immunoreactivity (F, red) associated with GFP-positive
astrocytic processes reveals localization of this receptor mainly in astrocytic
processes rather than in astrocytic cell bodies (G). [Note that we used an image
mask based on the GFP fluorescence of the astrocyte to display pixels display-
ing mGluR5 immunoreactivity associated with astrocytes (see SI Materials and
Methods).] Insets in G show regions 1 and 2 at higher magnification. (Scale
bars: E–G, 20 m; G Inset, 10 m.) (F Inset) Western blot analysis from isolated
NAc slices confirm the presence of the mGluR5 in this brain region . (H) NAc
slices from pGFAP-GFP mice loaded with Rhod-2 (red) showing selective
labeling of GFP expressing astrocytes (green). (Scale bar: 20 m.) (I)
Current-clamp recordings from a dye-loaded cell showing astrocytic mem-
brane properties and no action potential firing. (J) Average whole-cell I–V
relationship from dye-loaded cells (n  3 cells) and representative currents
after voltage steps from 115 mV to 25 mV (Inset). (K) Astrocyte responses
(time course of the F/F ratio) to DHPG (20 M; Upper) and ATP (100 M;
Lower). (L) Average percentage of astrocytes displaying Ca2 oscillations
under the different experimental conditions: ACSF, n  23 slices; DHPG (20
M), n  4 slices; DHPG (20 M)  MPEP (50 M), n  4 slices; ATP (50/100 M),
n  5 slices; baclofen (40 M), n  4 slices; low Ca2, n  5 slices; SKF 38393
(2.5–5 M), n  3 slices; quinpirole (20 M), n  3 slices; and cocaine (1–10 M),
n  4 slices.
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unaffected by the -amino-3-hydroxy-5-methyl-4-isoxazolepropi-
onic acid (AMPA)-receptor antagonist 6-cyano-2,3-dihydroxy-7-
nitro-quinoxaline disodium salt (CNQX, 25 M; SI Fig. 7E),
demonstrating that glutamate release from NAc astrocytes acti-
vates NMDA receptor in MSNs. Using NMDA receptor antago-
nists, we asked whether gliotransmission and synaptic transmission
access distinct types of NMDA receptors. Stimulation of glutama-
tergic afferents to MSNs evoked EPSCs that rely mainly on AMPA
receptors because the amplitude of EPSCs was reduced to 22  4%
by 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-
sulfonamide (NBQX) (30 M; n  18). The residual EPSC was
abolished by D-AP5 (50 M; data not shown). This synaptic NMDA
current is sensitive to the NR2A/C/D subunit-selective antagonist
NVP-AAM077 (0.4 M; n  6) (24, 25) and insensitive to the
NR2B subunit antagonist ifenprodil (5–10 M; n  6; Fig. 3 A–C)
(26). In contrast, glutamate-dependent gliotransmission is sensitive
to NR2B subunit antagonist ifenprodil but insensitive to NVP-
AAM077. In six MSNs displaying SIC activity, SICs amplitude was
reversibly decreased to 40  15% of control values by ifenprodil
(5–10 M; Fig. 3D). In contrast, in six cells NVP-AAM077 did not
decrease the amplitude of SICs (0.4 M; Fig. 3E). These results
show that astrocytic Ca2 oscillations induce NMDA receptor-
dependent SICs in MSNs, which are mediated by NR2B-containing
NMDA receptors, a distinct population from synaptic NMDA
receptors that, based on sensitivity to NVP-AAM077 (24, 25) and
their rapid decay kinetics (27) (SI Table 2), indicate that they are
mediated by NR1/NR2A-containing NMDA receptors.
Glutamategic Afferents Activate mGluR5-Dependent Gliotransmis-
sion. In light of the critical role of mGluR5 for mediating actions of
drugs of abuse (4–6), we determined the relative roles of this
receptor in regulating synaptic transmission and gliotransmission in
the NAc. We stimulated glutamatergic afferents that innervate the
NAc while monitoring excitatory postsynaptic potentials (EPSPs)
and SICs, respectively. DHPG did not change the strength of
synaptic transmission. In both field (n  6; Fig. 4A) and whole-cell
(n  6) recordings (Fig. 4B) DHPG had no effect on the field EPSP
and EPSC, respectively.
Stimulation of glutamatergic afferents initiated Ca2 oscillations
in astrocytes (Fig. 4 C and D) and significantly increased the
frequency of SICs in 9 of 21 MSNs tested (Fig. 4 E and F).
(Afferents were stimulated with 10 trains of stimuli repeated at 1-s
intervals. Individual trains consisted of seven stimuli at 30 Hz.)
Stimulation of glutamatergic afferents evoked Ca2 oscillations in
astrocytes that persisted for several minutes after the stimulus (Fig.
4C) and were judged to be due to neuronal activity because TTX
(1 M) blocked stimulus-induced Ca2 oscillations (Fig. 4D).
Addition of the mGluR5 antagonist MPEP (50 M) reversibly
reduced the activity-dependent induction of astrocytic Ca2 oscil-
lations consistent with afferent activity acting through mGluR5 to
stimulate astrocytes (Fig. 4D). Similar to Ca2 oscillations, SICs
were detected for minutes after afferent stimulation (Fig. 4 E and
F). Blockade of mGluR5 with MPEP (50 M) prevented the ability
of afferent stimulation to induce SICs (Fig. 4G). The suppressive
effect of MPEP on gliotransmission was not due to a reduction in
postsynaptic sensitivity to released glutamate because low Ca2
ACSF, which elevates astrocytic Ca2 independent of mGluRs (23),
was still able to stimulate SICs in the presence of MPEP (data not
shown). Taken together with the observation that DHPG elevates
astrocytic Ca2 and induces SICs, these data demonstrate that
mGluR5 is responsible for stimulating gliotransmission in response
to afferent stimulation.
Fig. 2. SICs evoked in MSNs by stimuli that induce astrocytic Ca2 oscillations.
(A) Patch-clamp recording from an MSN in voltage-clamp showing a sponta-
neous SIC after slice perfusion with 0 extracellular Mg2 ACSF. Note the slow
kinetics typical of SICs compared with miniature postsynaptic currents. Vh 
85 mV. (B) Histogram of rise (Left; 259 events; bin, 5 ms) and decay (Center;
259 events; bin, 50 ms) time of SICs. (Right) Overlay of an SIC (black trace) and
an EPSC (red trace). (C) Representative paired-recording from two MSNs
showing synchronous SICs. (D) Interevent time interval histogram of SICs
occurring in pairs of recorded MSNs (n  7 pairs). Of a total of 55 SICs, 16 SICs
were recorded within a time window of 200 ms. Bins, 50 ms. (E) SICs induced
by perfusion with DHPG (20 M); * indicates SIC. (F) Average SIC frequency in
ACSF, n  106 cells; 0 mM Mg2, n  147 cells; DHPG (20 M), n  15 cells; DHPG
(20 M)  MPEP (50 M), n  5 cells; ATP (50 M), n  9 cells; baclofen (40 M),
n  6 cells; SKF 38393 (2.5–5 M), n  5 cells; quinpirole (20 M), n  5 cells;
cocaine (1–10 M), n  9 cells; and low Ca2, n  95 cells.
Fig. 3. NR2B-containing NMDA receptors are the preferential target of astro-
cytic glutamate. (A) Ifenprodil (5/10 M) does not reduce the NMDA EPSC am-
plitude [averages of 10 excitatory postsynaptic potentials (EPSPs) in each condi-
tion]. Experiments performed in the presence of NBQX (30 M) and 0 Mg2. (B)
NR2A antagonist NVP-AAM077 (0.4 M) reduces NMDA receptor-mediated EPSC
amplitude. (C) Average amplitude of the NMDA EPSCs in the presence of ifen-
prodil (n  6 cells) and NVP-AAM077 (n  6 cells). Data are normalized to NMDA
EPSC amplitude before antagonist application. (D) Ifenprodil (5–10 M) reduces
SIC amplitude. (E) NR2A antagonist NVP-AAM077 (0.4 M) does not affect SIC
amplitude.
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Enhanced Gliotransmission at Up-State Membrane Potentials Evokes
Increased Action Potential Firing. Because glutamate-dependent
gliotransmission selectively activates NMDA receptors, it is impor-
tant to determine the impact of this signaling pathway on MSNs
under physiological concentrations of Mg2 and at membrane
potentials normally exhibited by MSNs. The MSNs of the NAc
exhibit up- and down-states in vivo that are characterized by bistable
states in which the membrane potential switches between approx-
imately 85 and 65 mV (28–30). Because the Mg2 block of
NMDA receptors can be reduced by depolarization, we asked
whether depolarized membrane potentials equivalent to the up-
state will enhance glutamate-dependent gliotransmission. In 1 mM
Mg2-containing ACSF and in the presence of TTX, to block
activity-dependent synaptic transmission, we recorded the fre-
quency of SICs in MSNs at holding potentials of 85 and 65 mV.
Depolarization from 85 to 65 mV increased the amplitude of
SICs from 42.0  7.1 to 73.7  12.4 pA (n  19; Fig. 5 A and
B). Coincident with this increased amplitude of SICs at up-state
membrane potentials was an increased frequency of detected SICs
(Fig. 5C) that probably results from an increased sensitivity to
detect SICs rather than to a true change in their frequency. In
contrast to the enhancement of SIC amplitude at up-state com-
pared with down-state membrane potentials, the amplitude of
evoked AMPA/NMDA EPSCs decreased with depolarization (Fig.
5 D and E) because of a reduced driving force for the AMPA
component of the EPSC, although the NMDA EPSC increased
similar to NMDA-mediated SICs (Fig. 5 D and E).
Because SIC but not EPSC amplitude is enhanced with depo-
larization from 85 to 65 mV, gliotransmission has the potential
to provide a powerful excitation to MSNs at up-state membrane
potentials. We therefore determined the impact of these SICs on
MSN excitability. Afferents were stimulated (10 trains of 7, 30-Hz
stimuli; Fig. 5F) to evoke delayed astrocytic Ca2 oscillations and
gliotransmission while making whole-cell recordings from pairs of
MSNs in 1 mM Mg2-containing ACSF (Fig. 5F). One neuron was
maintained in voltage-clamp to identify SICs while the paired
neuron was maintained in current-clamp to determine the impact
of SICs on neuronal activity (Fig. 5F). D-AP5 (50 M) prevented
the detection of delayed slow depolarizations and associated SICs
(n  7). At a membrane potential of approximately 65 mV, 46%
of gliotransmission-evoked depolarizations stimulated action po-
tentials with an average of 15.0  5.6 action potentials per event
(n  6; Fig. 5 F and I). In contrast, at a membrane potential of
approximately 85 mV, 38.4% of these astrocyte-dependent de-
polarizations evoked action potentials (3.0  1.1 action potentials
per event, n  5; Fig. 5 G and I).
Discussion
Given the importance of mGluR5 in mediating self-administration
of cocaine and locomotor activity (4–6), it is essential that an
understanding of the mechanisms of mGluR5 signaling is identi-
fied. We show that the activation of mGluR5 in the NAc activates
Ca2 oscillations in astrocytes that lead to the Ca2-dependent
release of glutamate from these glia. This glial-derived glutamate
selectively activates NR2B-containing neuronal NMDA receptors
of MSNs. Direct excitation of MSNs by afferents is not acutely
modulated by mGluR5, although other reports have shown the
potential to induce synaptic plasticity (31). Instead, glutamate
released from these glutamatergic afferents is responsible for
inducing mGluR5-dependent gliotransmission. Thus, activity of
afferents has two mechanisms for MSN excitation: direct synaptic
activation, and an indirect pathway mediated by mGluR5 and
gliotransmission.
Of particular interest is the prolonged activation of gliotransmis-
sion by afferent activity. A brief train of stimuli delivered to the
afferents evoked astrocytic Ca2 oscillations and gliotransmission
for several minutes (Fig. 4C). A prolonged response of astrocytes
to a brief stimulus has been reported previously. In hippocampal
slices, repeated application of the mGluR agonist, trans-ACPD,
leads to a prolonged enhancement in Ca2 oscillation frequency in
response to subsequent challenges with this agonist (32). Stimula-
tion of the Schaffer collaterals induces gliotransmission detected in
Fig. 4. Glutamatergic afferents activate
mGluR5-dependent gliotransmission. (A)
mGluR5 receptors do not modulate glutamater-
gic synaptic transmission. (A Left) Field EPSPs un-
der control conditions, in the presence of DHPG
(20 M) and NBQX (30 M). The arrow indicates
theEPSP. (ARight)AverageslopeoffieldEPSPs in
thepresenceofMPEP (50 M)andDHPG(20 M)
(n  6 slices). (B) Whole-cell recording showing
that EPSC amplitude is not affected by DHPG
application (n  6 cells). (C) Astrocyte responses
(time course of the F/F ratio) to glutamatergic
afferent stimulation. Afferents were stimulated
by using 10 trains of seven stimuli delivered at 30
Hz. (D)Averagepercentageofastrocytesdisplay-
ingCa2 oscillationsduringthesequentialexper-
imental conditions (n  5): glutamatergic affer-
ent stimulation, in ACSF, MPEP (50 M), after
washout of MPEP, and in the presence of TTX (1
M). (E) Whole-cell recordings in Mg2-free
ACSF showing two SICs triggered by stimulus
trains (10 trains of seven stimuli delivered at 30
Hz) applied to the glutamatergic afferents. See
Inset for one train of seven stimuli at an ex-
pandedtimescale. (Scalebar:50ms,50pA.)Note
that stimulation of glutamatergic afferent elicits
a prolonged increase in SIC frequency. (F) Aver-
age SIC frequency in a 3-min time period before
and after glutamatergic afferent stimulation
(n  9 cells). (G) Blockade of mGluR5 by MPEP
prevents the ability of glutamatergic afferent
stimulation to trigger SICs (MPEP 50 M, n  5).
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CA1 pyramidal neurons that can be detected for minutes after the
stimulus (15). Chemically induced epileptiform activity increases
astrocytic Ca2 oscillation frequency and gliotransmission that lasts
for minutes after the termination of neuronal activity by TTX (33).
In the NAc, such persistent activation of gliotransmission has the
potential to provide long-lasting changes in MSN excitability.
Glutamate-Dependent Gliotransmission Excites GABAergic Neurons.
Our results show that, by generating SICs, gliotransmission excites
GABAergic neurons. Previous studies performed in the thalamus
(34), cortex, and hippocampus (15, 19, 33) have shown that Ca2
elevations in astrocytes lead to the Ca2-dependent release of
glutamate that cause NMDA receptor-mediated currents in gluta-
matergic neurons. By performing this study in the NAc, where
90–95% of the neuronal population is composed of MSNs (35,
36), a class of GABAergic cell, we have been able to demonstrate
that glutamate-dependent gliotransmission is a general property of
the CNS, and that gliotransmission excites both glutamatergic and
GABAergic neurons.
Gliotransmission Acts Preferentially on NR2B-Containing NMDA Re-
ceptors. In the NAc, the properties of gliotransmission are similar
to those reported in other regions of the CNS. Glial-dependent
SICs exhibit many properties that distinguish them from glutamate-
dependent synaptic currents: slow kinetics, and insensitivity to TTX
and 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline disodium salt
(CNQX). Previous studies in the hippocampus using ifenprodil
suggested an extrasynaptic target action for glial-derived glutamate
(15). In this study, we have evaluated this possibility using antag-
onists that act on NR2B subunit-containing NMDA receptors and
NR2A-containing receptors. Because we see distinct pharmaco-
logical sensitivity of afferent synaptic transmission and gliotrans-
mission, we can conclude that gliotransmission acts preferentially
on NR2B-containing NMDA receptors presumably located at
extrasynaptic sites. Whether gliotransmission affects other extra-
synaptic receptors is unknown at this time. This is of particular
interest because glutamate arising from a cysteine-glutamate ex-
changer is known to access extrasynaptic mGluR2/3 (37). Ca2-
regulated glutamate-dependent gliotransmission is a general prop-
erty of the nervous system that is present in distinct brain regions,
including the thalamus (34), area CA1 and CA3 of the hippocampus
(15, 33), cortex, and olfactory bulb (33, 38), and the NAc. Glio-
transmission is mediated through extrasynaptic NMDA receptors
of glutamatergic (15) and GABAergic neurons.
Gating Gliotransmission. In the NAc, MSNs exhibit up- and down-
states in which the membrane potential oscillates between approx-
imately 85 and 65 mV (30). Because the Mg2 block of the
NMDA receptor is membrane potential-dependent, we asked
whether depolarized membrane potentials associated with up-
Fig. 5. Gliotransmission drives increased action
potential generation in MSNs at up-state membrane
potentials. (A) Average traces of SICs (n  19) at
holding potentials of 85 and 65 mV showing the
enhancement of SIC amplitude at up-state (65 mV)
comparedwithdown-state (85mV)membranepo-
tentials (error bars are SEM). All experiments re-
ported in this figure were made in 1 mM Mg2-
containing ACSF. (B) Average amplitude of the SICs
at the two different holding potentials. (C) Average
SIC frequency after stimulation of class I mGluRs with
DHPG (20 M) at Vh of 85 and 65 mV (n  10). (D)
The EPSC (Left) and pure NMDA-mediated EPSC
(Right) at holding potentials of 85 and 65 mV.
NMDA currents were recorded in NBQX (30 M).
Note the reduction of EPSC amplitude at up-state
(65 mV) compared with down-state (85 mV)
membrane potentials in contrast to the augmenta-
tion of the SIC (A). Traces in D are averages of 10
evoked EPSCs. (E) 65/85 mV ratio of amplitude
the EPSC and pure NMDA-mediated EPSC currents at
the two different voltages (n  5). (F) Paired whole-
cell recordings from two closely spaced MSNs in
Mg2-containing ACSF. Glutamatergic afferents
were stimulated with 10 trains of seven 30-Hz stimuli
(one train shown) that evoked EPSPs in the neuron
recorded in current-clamp (Upper) and EPSCs in the
voltage-clamped neuron (Lower). With a delay after
afferent stimulation, synchronous excitation of
paired MSNs show that gliotransmission powerfully
excitesMSNstogenerateaburstofactionpotentials.
(G) In contrast, gliotransmission evokes few action
potentials when MSNs are at down-state membrane
potentials. (H) Comparison on the kinetics of SICs at
up- and down-state membrane potentials (n  13
events). (I) Average number of action potentials dur-
inggliotransmission-mediateddepolarization (black
bars, n  6; gray bars, n  5).
D’Ascenzo et al. PNAS  February 6, 2007  vol. 104  no. 6  1999
N
EU
RO
SC
IE
N
CE
states would, by removing the Mg2 block of the NMDA receptor,
enhance the detection of SICs. We detected SICs with a higher
frequency at this depolarized membrane potential (Fig. 5), sug-
gesting that the up-state will gate glutamate-dependent gliotrans-
mission and provide the opportunity for this excitatory pathway to
regulate neuronal excitability. Indeed, it is clear that NMDA
receptors provide the opportunity for supralinear amplification (39,
40) and that NMDA receptors are required to boost the excitability
of MSN neurons (30). In a combined electrophysiology and mod-
eling study, a synaptic NMDA/AMPA receptor ratio of 50%, based
on values measured in pyramidal neurons, was used to show the
importance of the synaptic NMDA receptor in contributing to
neuronal excitability (30). Given that our measurements show the
actual ratio to be only 22%, it is possible that the NR2B-containing
NMDA receptors activated by gliotransmission contribute to this
process of up-state amplification.
Gliotransmission and CREB Phosphorylation. Because the extrasyn-
aptic NMDA receptor density is lower than the synaptic receptor
density (41), it is likely that the majority of glial-induced NMDA
receptor responses have gone undetected by our recordings and
that their main role is not to regulate membrane potential (42).
Although we observe gliotransmission-induced NMDA receptor-
mediated currents in MSNs, it is likely that an important action of
this receptor is in mediating biochemical signaling within the target
neuron rather than membrane potential changes per se. Several lines
of evidence suggest that NMDA receptors may produce diverse
outcomes depending on their subunit composition. Whereas the
NR2A-containing NMDA receptors stimulate phosphorylation of
CREB that drives transcription, activation of NR2B-containing
receptors leads to CREB dephosphorylation (43) and to opposing
actions. In the NAc, CREB phosphorylation has a particularly
critical role in mediating the behavioral response to drug abuse (44).
Recent work demonstrated that the increased NAc MSNs excit-
ability caused by CREB helped to limit behavioral sensitivity to
cocaine (45). Because glial-derived glutamate acts preferentially
through extrasynaptic NR2B-containing NMDA receptors that
have been shown to lead to dephosphorylation of CREB (43), it is
possible that this mGluR5-induced gliotransmission maintains or
enhances responses to drugs of abuse.
In conclusion, we demonstrate that mGluR5 triggers astrocytic
Ca2 oscillations and, as a consequence, gliotransmission. Stimu-
lation of glutamatergic afferents, a major excitatory pathway that
innervates the NAc, induces persistent gliotransmission that acti-
vates NR2B-containing NMDA receptors of MSNs located pre-
sumably at extrasynaptic sites. Because stimulation of mGluR5
triggers gliotransmission with no effect on synaptic transmission,
our results raise the potential for the involvement of gliotransmis-
sion in mediating aspects of mGluR5-dependent drug-induced
behaviors.
Materials and Methods
Slice Preparation. All procedures were in accordance with the Guide
for the Care and Use of Laboratory Animals (National Institutes of
Health) and were approved by the University of Pennsylvania’s
institutional animal care and use committee. Coronal and sagittal
slices containing the NAc (250–400 m) from 2- to 6-week-old
C57BL/6 and FVB/NJ mice were prepared (46). Experiments
presented in SI Fig. 7 were performed on 9- to 14-day-old pups.
After cervical dislocation, the brain was rapidly removed and put in
an ice-cold cutting solution containing 120 mM NaCl, 3.2 mM KCl,
1 mM KH2PO4, 26 mM NaHCO3, 2 mM MgCl2, 1 mM CaCl2, 10
mM glucose, 2 mM Na-pyruvate, and 0.6 mM ascorbic acid (pH 7.4,
95% O2/5% CO2).
Electrophysiology. Slices were continuously perfused with normal
ACSF [120 mM NaCl/3.2 mM KCl/1 mM KH2PO4/26 mM
NaHCO3/1 mM MgCl2/2 mM CaCl2/10 mM glucose (pH 7.4,
95% O2/5% CO2, 32°C)]. Intrapipette solution contained 145
mM K-gluconate, 2 mM MgCl2, 5 mM EGTA, 2 mM Na2ATP,
0.2 mM NaGTP, and 10 mM Hepes (pH 7.2 with KOH). Pipette
resistance was 3–4 M. The pipette tip liquid junction potential
(15 mV) was added to all voltages to obtain the correct value
of the membrane potential. Recordings were performed from
the core region of the NAc. A bipolar tungsten electrode
(Warner Instruments, Hamden, CT) was positioned 200–300 m
rostral to the recording electrode and was used to stimulate
excitatory afferents at 0.05–0.1 Hz. Inward currents with a rise
time of 	10 ms, a decay time of 	50 ms, and an amplitude of
	10 pA were classified as SICs as described (15). Rise time of
both SICs and EPSCs was calculated by using a 20–80%
criterion, and the amplitude was measured at the peak. The
decay time was calculated as the time constant of a single or
double exponential fit. Data are expressed as mean  SEM.
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